HUTCHMED (China) Limited
HCM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $630 | $838 | $426 | $356 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | $349 | $384 | $311 | $258 |
| Gross Profit | $281 | $454 | $115 | $98 |
| % Margin | 44.6% | 54.1% | 27% | 27.5% |
| R&D Expenses | $213 | $303 | $268 | $207 |
| G&A Expenses | $64 | $80 | $92 | $89 |
| SG&A Expenses | $113 | $133 | $136 | $127 |
| Sales & Mktg Exp. | $49 | $53 | $44 | $38 |
| Other Operating Expenses | -$4 | $0 | $119 | $92 |
| Operating Expenses | $322 | $436 | $523 | $426 |
| Operating Income | -$44 | $18 | -$410 | -$344 |
| % Margin | -6.9% | 2.2% | -96.1% | -96.7% |
| Other Income/Exp. Net | $89 | $87 | $52 | $189 |
| Pre-Tax Income | $45 | $106 | -$360 | -$155 |
| Tax Expense | $7 | $5 | -$0 | $12 |
| Net Income | $38 | $101 | -$361 | -$195 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.22 | 0.6 | -2.15 | -1.25 |
| % Growth | -63.3% | 127.9% | -72% | – |
| EPS Diluted | 0.22 | 0.6 | -2.15 | -1.25 |
| Weighted Avg Shares Out | 171 | 170 | 169 | 159 |
| Weighted Avg Shares Out Dil | 175 | 174 | 169 | 159 |
| Supplemental Information | – | – | – | – |
| Interest Income | $40 | $36 | $10 | $2 |
| Interest Expense | $3 | $1 | $1 | $1 |
| Depreciation & Amortization | $12 | $8 | $9 | $7 |
| EBITDA | $14 | $67 | -$401 | -$208 |
| % Margin | 2.2% | 8% | -94.1% | -58.4% |